In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model, Infection, vol.30, issue.5, pp.286-291, 2002. ,
DOI : 10.1007/s15010-002-2131-0
in immunocompromised mice, Journal of Antimicrobial Chemotherapy, vol.35, issue.5, pp.631-640, 1995. ,
DOI : 10.1093/jac/35.5.631
Ura-status-dependent adhesion of Candida albicans mutants, FEMS Microbiology Letters, vol.204, issue.2, pp.323-328, 2001. ,
DOI : 10.1111/j.1574-6968.2001.tb10905.x
Comparison of the Fungicidal Activities of Caspofungin and Amphotericin B against Candida glabrata, Antimicrobial Agents and Chemotherapy, vol.49, issue.12, pp.4989-4992, 2005. ,
DOI : 10.1128/AAC.49.12.4989-4992.2005
Candida albicans Pmr1p, a Secretory Pathway P-type Ca2+/Mn2+-ATPase, Is Required for Glycosylation and Virulence, Journal of Biological Chemistry, vol.280, issue.24, pp.23408-23415, 2005. ,
DOI : 10.1074/jbc.M502162200
Comparison of Pathogenesis and Host Immune Responses to Candida glabrata and Candida albicans in Systemically Infected Immunocompetent Mice, Infection and Immunity, vol.69, issue.8, pp.5046-5055, 2001. ,
DOI : 10.1128/IAI.69.8.5046-5055.2001
Protection of peritoneal macrophages by granulocyte/macrophage colony-stimulating factor (GM-CSF) against dexamethasone suppression of killing of Aspergillus, and the effect of human GM-CSF, Microbes and Infection, vol.4, issue.2, pp.133-138, 2002. ,
DOI : 10.1016/S1286-4579(01)01519-2
Role of Granulocyte Macrophage Colony-Stimulating Factor in Host Defense Against Pulmonary Cryptococcus neoformans Infection during Murine Allergic Bronchopulmonary Mycosis, The American Journal of Pathology, vol.170, issue.3, pp.1028-1040, 2007. ,
DOI : 10.2353/ajpath.2007.060595
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus, Infect. Immun, vol.64, pp.4401-4405, 1996. ,
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans, Clin. Microbiol. Rev, vol.12, pp.80-96, 1999. ,
Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment, Genetics, vol.159, pp.499-513, 2001. ,
The changing epidemiology of invasive candidiasis, Cancer, vol.37, issue.11, pp.2493-2499, 2008. ,
DOI : 10.1002/cncr.23466
Vaccination of corticosteroid immunosup- 1076 JACOBSEN ET AL, INFECT. IMMUN, 2002. ,
The p47phox mouse knock-out model of chronic granulomatous disease, Journal of Experimental Medicine, vol.182, issue.3, pp.751-758, 1995. ,
DOI : 10.1084/jem.182.3.751
Efficacies of Fluconazole, Caspofungin, and Amphotericin B in Candida glabrata-Infected p47phox-/- Knockout Mice, Antimicrobial Agents and Chemotherapy, vol.46, issue.5, pp.1240-1245, 2002. ,
DOI : 10.1128/AAC.46.5.1240-1245.2002
A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata, Proceedings of the National Academy of Sciences, vol.3, issue.14-15, pp.7628-7633, 2007. ,
DOI : 10.1016/S1286-4579(01)01496-4
Pathogenicity of Candida albicans auxotrophic mutants in experimental infections, Infect. Immun, vol.59, pp.3297-3300, 1991. ,
Myeloperoxidase: friend and foe, Journal of Leukocyte Biology, vol.77, issue.5, pp.598-625, 2005. ,
DOI : 10.1189/jlb.1204697
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models, Gastroenterology, vol.87, pp.1344-1350, 1984. ,
Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis, Infect. Immun, vol.67, pp.6637-6642, 1999. ,
Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models, Microbial Pathogenesis, vol.42, issue.4, pp.138-147, 2007. ,
DOI : 10.1016/j.micpath.2006.12.003
Quantification of bovine neutrophil migration across mammary epithelium in vitro, Can. J. Vet. Res, vol.60, pp.145-149, 1996. ,
in the kidney in a murine intravenous challenge model, FEMS Yeast Research, vol.9, issue.7, pp.1111-1122, 2009. ,
DOI : 10.1111/j.1567-1364.2009.00576.x
Early-Expressed Chemokines Predict Kidney Immunopathology in Experimental Disseminated Candida albicans Infections, PLoS ONE, vol.280, issue.7, p.6420, 2009. ,
DOI : 10.1371/journal.pone.0006420.s001
Candida glabrata Fungemia: Experience in a Tertiary Care Center, Clinical Infectious Diseases, vol.41, issue.7, pp.975-981, 2005. ,
DOI : 10.1086/432939
Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata, Journal of Antimicrobial Chemotherapy, vol.61, issue.4, pp.880-883, 2008. ,
DOI : 10.1093/jac/dkn028
Determinants of mortality in non-neutropenic ICU patients with candidaemia, Critical Care, vol.13, issue.4, p.115, 2009. ,
DOI : 10.1097/00005792-200305000-00005
Development, differentiation , and phenotypic heterogeneity of murine tissue macrophages, J. Leukoc . Biol, vol.59, pp.133-138, 1996. ,
Strains and Strategies for Large-Scale Gene Deletion Studies of the Diploid Human Fungal Pathogen Candida albicans, Eukaryotic Cell, vol.4, issue.2, pp.298-309, 2005. ,
DOI : 10.1128/EC.4.2.298-309.2005
Candida and candidosis, pp.68-93, 1988. ,
Nosocomial fungal infections: epidemiology, diagnosis, and treatment, Medical Mycology, vol.45, issue.4, pp.321-346, 2007. ,
DOI : 10.1080/13693780701218689
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, issue.1, pp.133-163, 2007. ,
DOI : 10.1128/CMR.00029-06
Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp., Critical Care Medicine, vol.36, issue.7, pp.2034-2039, 2008. ,
DOI : 10.1097/CCM.0b013e3181760f42
Intranasal Granulocyte-Macrophage Colony-Stimulating Factor Reduces the Aspergillus Burden in an Immunosuppressed Murine Model of Pulmonary Aspergillosis, Antimicrobial Agents and Chemotherapy, vol.52, issue.2, pp.716-718, 2008. ,
DOI : 10.1128/AAC.00760-07
The SAT1 flipper, an optimized tool for gene disruption in Candida albicans, Gene, vol.341, pp.119-127, 2004. ,
DOI : 10.1016/j.gene.2004.06.021
The predictors of outcome in immunocompetent patients with hematogenous candidasis, International Journal of Infectious Diseases, vol.8, issue.3, pp.180-186, 2004. ,
DOI : 10.1016/j.ijid.2003.05.003
Infection of Human Oral Epithelia with Candida Species Induces Cytokine Expression Correlated to the Degree of Virulence, Journal of Investigative Dermatology, vol.118, issue.4, pp.652-657, 2002. ,
DOI : 10.1046/j.1523-1747.2002.01699.x
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007), Cancer, vol.5, issue.20, pp.4745-4752, 2001. ,
DOI : 10.1002/cncr.24507
Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B, J. Antimicrob. Chemother, vol.59, pp.941-951, 2007. ,
Mice with Disseminated Candidiasis Die of Progressive Sepsis, The Journal of Infectious Diseases, vol.192, issue.2, pp.336-343, 2005. ,
DOI : 10.1086/430952
Dark brown is the more virulent of the switch phenotypes of Candida glabrata, Microbiology, vol.154, issue.11, pp.3309-3318, 2008. ,
DOI : 10.1099/mic.0.2008/020578-0
URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes, Trends in Microbiology, vol.11, issue.2, pp.69-73, 2003. ,
DOI : 10.1016/S0966-842X(02)00029-X
Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions, Nature Genetics, vol.7, issue.2, pp.199-206, 2007. ,
DOI : 10.1038/ng1948
Complement C3 Plays an Essential Role in the Control of Opportunistic Fungal Infections, Infection and Immunity, vol.77, issue.9, pp.3679-3685, 2009. ,
DOI : 10.1128/IAI.00233-09
Infrared body temperature measurement of mice as an early predictor of death in experimental fungal infections, Laboratory Animals, vol.37, issue.2, pp.126-131, 2003. ,
DOI : 10.1258/00236770360563769